The ACC Electrophysiology (EP) Section along with the Heart Rhythm Society COVID-19 Task Force, and the American Heart Association's Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, has released new guidance for cardiac electrophysiology during COVID-19.

The document, which is broken down in 10 key areas, highlights the scope of the program and addresses "potential risks of exposure to patients, physicians, allied health care staff, industry representatives and hospital administrators."

It also looks at the impact of COVID-19 on cardiac arrhythmias; addresses triage of procedures based on screening and personal protective equipment; and provides guidance for managing invasive and noninvasive EP procedures, clinic visits and cardiac implantable electronic device interrogation. Read more.